{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:25:47Z","timestamp":1793831147823,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ahj.2024.05.019","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T06:33:00Z","timestamp":1717482780000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial"],"prefix":"10.1016","volume":"275","author":[{"given":"Lei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2024.05.019_bib0001","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.05.019_bib0002","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2024.05.019_bib0003","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4244\/EIJ-D-17-00499","article-title":"State of the art: the inception, advent and future of fully bioresorbable scaffolds","volume":"13","author":"Katagiri","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2024.05.019_bib0004","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","article-title":"2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy","volume":"390","author":"Ali","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.05.019_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.05.019_bib0006","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.117.028479","article-title":"Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: a meta-analysis of randomized controlled trials","volume":"135","author":"Montone","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.05.019_bib0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jacc.2023.05.003","article-title":"5-year outcomes after bioresorbable coronary scaffolds implanted with improved technique","volume":"82","author":"Stone","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.05.019_bib0008","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2023.05.023","article-title":"Bioresorbable scaffolds: is there still light at the end of the tunnel?","volume":"82","author":"Serruys","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.05.019_bib0009","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4244\/EIJ-D-17-00254","article-title":"Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III","volume":"13","author":"Haude","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2024.05.019_bib0010","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.119.043467","article-title":"Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with st-segment elevation myocardial infarction: the MAGSTEMI randomized clinical trial","volume":"140","author":"Sabat\u00e9","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.05.019_bib0011","first-page":"222","article-title":"First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trial","volume":"19","author":"Gao","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2024.05.019_bib0012","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2024.05.019_bib0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcin.2018.10.020","article-title":"Preclinical evaluation of a novel sirolimus-eluting iron bioresorbable coronary scaffold in porcine coronary artery at 6 months","volume":"12","author":"Zheng","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2024.05.019_bib0014","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.jacc.2017.10.035","article-title":"Diagnostic accuracy of angiography-based quantitative flow ratio measurements for online assessment of coronary stenosis","volume":"70","author":"Xu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.05.019_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCINTERVENTIONS.108.831800.108.831800","article-title":"Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial","volume":"2","author":"Claessen","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2024.05.019_bib0016","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial","volume":"299","author":"Stone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2024.05.019_bib0017","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"ABSORB Japan investigators. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2024.05.019_bib0018","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcin.2017.09.037","article-title":"A randomized trial comparing the neovas sirolimus-eluting bioresorbable scaffold and metallic everolimus-eluting stents","volume":"11","author":"Han","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2024.05.019_bib0019","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.4244\/EIJ-D-17-00461","article-title":"Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy","volume":"14","author":"Asano","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2024.05.019_bib0020","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4244\/EIJY16M09_01","article-title":"Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial","volume":"12","author":"Onuma","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2024.05.019_bib0021","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)61765-6","article-title":"Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"381","author":"Haude","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.05.019_bib0022","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.4244\/EIJ-D-23-00326","article-title":"A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study","volume":"19","author":"Haude","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2024.05.019_bib0023","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.4244\/EIJ-D-21-00651","article-title":"Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial","volume":"18","author":"Ortega-Paz","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2024.05.019_bib0024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1540-8183.2007.00319.x","article-title":"Short-term effects of biocorrodible iron stents in porcine coronary arteries","volume":"21","author":"Waksman","year":"2008","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.ahj.2024.05.019_bib0025","doi-asserted-by":"crossref","first-page":"eabf0614","DOI":"10.1126\/sciadv.abf0614","article-title":"PDLLA-Zn-nitrided Fe bioresorbable scaffold with 53-\u00b5m-thick metallic struts and tunable multistage biodegradation function","volume":"7","author":"Shen","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.ahj.2024.05.019_bib0026","doi-asserted-by":"crossref","first-page":"e0016","DOI":"10.5041\/RMMJ.10402","article-title":"Bioresorbable scaffolds: current technology and future perspectives","volume":"11","author":"Forrestal","year":"2020","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.ahj.2024.05.019_bib0027","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.matdes.2015.11.045","article-title":"Design and characterization of a novel biocorrodible ironbased drug-eluting coronary scaffold","volume":"91","author":"Lin","year":"2016","journal-title":"Mater Design"},{"key":"10.1016\/j.ahj.2024.05.019_bib0028","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.actbio.2017.03.020","article-title":"Long-term in vivo corrosion behavior, 2biocompatibility and bioresorption mechanism of a bioresorbable nitrided iron scaffold","volume":"54","author":"Lin","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ahj.2024.05.019_bib0029","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(21)02248-0","article-title":"Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial","volume":"398","author":"Xu","year":"2021","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324001406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324001406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T13:34:14Z","timestamp":1732368854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870324001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":29,"alternative-id":["S0002870324001406"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2024.05.019","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2024.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}